ASTHNasdaqServices-Management Consulting ServicesUS GAAP · USD

Astrana Health, Inc.

Astrana Health, Inc. is a physician-centric healthcare management company built around a technology-enabled, risk-bearing model for value-based care. It works through affiliated physician groups, independent risk-bearing organizations, and consolidated subsidiaries to coordinate care for managed patients covered by Medicare, Medicaid, HMOs, employer plans, and other health coverage arrangements. The company’s platform combines population health management, care coordination, medical coding, and risk management tools to help providers deliver lower-cost, higher-quality care. Astrana also operates a California Restricted Knox-Keene-licensed health plan, an MSO, specialty pharmacy, and, after the Prospect acquisition, a fully accredited acute care hospital. Its business is concentrated in California and is designed to capture recurring revenue from capitation, risk pools, management fees, and fee-for-service arrangements.

Revenue3,182m USD
+56.4 %y/y
Operating profit (EBIT)78.5m USD
−12.1 %y/y
EBIT margin2.5%
−1.9 ppy/y
Net income22.5m USD
−47.9 %y/y
Free cash flow104m USD
+136.6 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

01,0002,0003,0004,000m USD2020: 687 m USD2020: EBIT 81 m USD20202021: 774 m USD2021: EBIT 98 m USD20212022: 1,144 m USD2022: EBIT 104 m USD20222023: 1,387 m USD2023: EBIT 85 m USD20232024: 2,035 m USD2024: EBIT 89 m USD20242025: 3,182 m USD2025: EBIT 79 m USD20253,18279
RevenueOperating profit (EBIT)

Products

Reported · share of revenue
91.9%FY2025100 %
  • Health Care Capitation Revenue91.9 %
  • Health Care Patient Service3.5 %
  • Health Care Other2.7 %
  • Management Service1.0 %
  • Other0.9 %

Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Geography

Astrana’s business is concentrated in the United States, with management repeatedly describing its patient base as primarily in California. The Prospect acquisition materially expanded the company’s provider network and added assets including a California Restricted Knox-Keene-licensed health plan and a hospital, reinforcing the company’s California-centered operating footprint. The company’s revenue exposure is therefore tied to U.S. healthcare reimbursement, state regulation, and payer mix rather than international markets. Because the model depends on local physician networks, health-plan relationships, and state licensing, geographic concentration is strategically important and also increases regulatory and reimbursement exposure in California.

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026